neurodegenerative diseases
Jump to
18 Results Found
  • Suven Life secures neuro drug patent from Australia Jul 21, 2017 01:05 PM IST

    Suven Life secures neuro drug patent from Australia

    The company has been granted one product patent from Australia corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with neurodegenerative diseases, it said in a BSE filing.

  • Suven Life secures 2 product patents in Israel & Mexico; up 3% Jun 03, 2016 11:52 AM IST

    Suven Life secures 2 product patents in Israel & Mexico; up 3%

    The company has been granted one product patent from Israel and one product patent from Mexico corresponding to the new chemical entities for the treatment of disorders associated with Neurodegenerative diseases.

  • Suven Life gets patents for neuro-degenerative drug Jun 03, 2016 11:33 AM IST

    Suven Life gets patents for neuro-degenerative drug

    In a BSE filing today, Suven Life said it has beengranted "one product patent from Israel and one product patent from Mexico corresponding to the New Chemical Entities (NCEs)for the treatment of disorders associated withNeurodegenerative diseases".

  • Suven Life jumps 3% on patents in Canada, ARIPO, South Korea Jan 05, 2016 10:24 AM IST

    Suven Life jumps 3% on patents in Canada, ARIPO, South Korea

    "Suven announced today that grant of one product patent each from Canada, ARIPO and South Korea corresponding to new chemical entities for treatment of disorders associated with neurodegenerative diseases," says the biopharmaceutical company in its filing.

  • Suven Life rises 5% on product patents in Europe, Macau Dec 29, 2015 10:27 AM IST

    Suven Life rises 5% on product patents in Europe, Macau

    "Suven announced that grant of one product patent from Europe and one patent from Macau corresponding to new chemical entities for treatment of disorders associated with neurodegenerative diseases," says the Hyderabad-based biopharmaceutical company in its filing.

  • Suven Life gets patents for neurodegenerative drug Sep 16, 2015 01:15 PM IST

    Suven Life gets patents for neurodegenerative drug

    In a BSE filing, the company said it has been granted "two product patents from Canada and one product patent from China corresponding to their New Chemical Entities (NCEs) for the treatment of disorders associated with neurodegenerative diseases." These patents are valid through 2029 and 2030, the company added.

  • Suven Life rises 6% on 3 product patents in Canada, China Sep 16, 2015 11:38 AM IST

    Suven Life rises 6% on 3 product patents in Canada, China

    With these new patents, Suven has a total of 20 granted patents from Canada and 18 granted patents from China.

  • Suven Life Sciences gets patents for neurodegenerative drug Jun 16, 2015 12:00 PM IST

    Suven Life Sciences gets patents for neurodegenerative drug

    Biopharmaceutical firm Suven Life Sciences on Tuesday said it has been granted one patent each by the US, Israel and Macau for a drug used in the treatment of neurodegenerative diseases.

  • Suven Life Sciences gets patents for neurological drug May 13, 2015 12:38 PM IST

    Suven Life Sciences gets patents for neurological drug

    Neurodegenerative diseases include Alzheimer's, Schizophrenia and Parkinson's. In a BSE filing, the company said it has been granted "one product patent from Europe and one product patent from Hong Kong corresponding to the new chemical entities for the treatment of disorders associated with neurodegenerative diseases".

  • Suven Life up 9% on product patents in Canada, Japan, Korea Mar 24, 2015 02:50 PM IST

    Suven Life up 9% on product patents in Canada, Japan, Korea

    Shares of Suven Life Sciences rallied 8.6 percent intraday Tuesday on getting three product patents for NCEs in Canada, Japan and Korea.

  • Suven Life up 5%, gets product patent in Eurasia & Israel Mar 09, 2015 11:27 AM IST

    Suven Life up 5%, gets product patent in Eurasia & Israel

    Shares of Suven Life Sciences (Suven) climbed 5 percent intraday Monday on getting product patent each in Eurasia and Israel.

  • Suven Life Sciences gets patents for neurodegenerative drug Jan 20, 2015 12:27 PM IST

    Suven Life Sciences gets patents for neurodegenerative drug

    The company said it has been granted one product patent from Australia, two product patents from Japan and one product patent from Hong Kong corresponding to the New Chemical Entity (NCE) for the treatment of disorders associated with Neurodegenerative diseases.

  • Suven gains 6% on product patents in Eurasia, Japan, Mexico Dec 30, 2014 12:52 PM IST

    Suven gains 6% on product patents in Eurasia, Japan, Mexico

    These patents are corresponding to the new chemical entities (NCEs) for the treatment of disorders associated with neurodegenerative diseases and these patents are valid through 2029, said the pharma company in its filing to the exchange.

  • Suven Life soars 7%, gets 5 product patents in 4 countries Dec 12, 2014 11:34 AM IST

    Suven Life soars 7%, gets 5 product patents in 4 countries

    Suven today received the two product patents from Israel, one product patent each from Japan, China and New Zealand corresponding to the new chemical entities (NCEs) for the treatment of disorders associated with neurodegenerative diseases.

  • Suven Life Sciences up 5%, gets patents in South Korea, US Oct 13, 2014 11:09 AM IST

    Suven Life Sciences up 5%, gets patents in South Korea, US

    These patents are related to the new chemical entity (NCE) for the treatment of disorders associated with neurodegenerative diseases and are valid through 2030.

  • Will need 3-4 years for new patents' materialisation: Suven Jan 01, 2013 02:53 PM IST

    Will need 3-4 years for new patents' materialisation: Suven

    Suven Life Sciences secured three product patents (two from Eurasia and one from Canada) corresponding to the new chemical entities for the treatment of disorders associated with Neurodegenerative diseases. The patents are valid through 2027. The company's stocks rallied 5% on the news.

  • Suven Life gets four patents for new chemical entities Aug 18, 2011 11:34 AM IST

    Suven Life gets four patents for new chemical entities

    Suven Life Sciences has received four product patents for their new chemical entities (NCE) for treatment of disorders associated with neurodegenerative disorders like Alzheimer’s, Attention Deficit Hyperactivity Disorder (ADHD), Huntington’s disease, Parkinson and Schizophrenia.

  • Suven gets 4 product patents for several key markets May 26, 2011 11:35 AM IST

    Suven gets 4 product patents for several key markets

    Suven Life Science Monday said it has got product patent for its new chemical entity, 5-HT compounds used to treat neurodegenerative diseases like Parkinson and Schizophrenia from Europe, New Zealand, Australia and Korea.

Sections